Page last updated: 2024-12-10

19-hydroxyprostaglandin e2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

## 19-Hydroxyprostaglandin E2 (19-OH-PGE2)

19-Hydroxyprostaglandin E2 (19-OH-PGE2) is a **metabolite** of prostaglandin E2 (PGE2), a crucial signaling molecule involved in various physiological processes. Here's a breakdown of its significance:

**What it is:**

* **Prostaglandins:** Lipid-based molecules produced in various tissues with diverse roles. They are involved in inflammation, pain, fever, blood clotting, and more.
* **PGE2:** A specific prostaglandin with a wide range of actions. It is known for its role in inflammation, immune regulation, and pain perception.
* **19-OH-PGE2:** A derivative of PGE2 formed through a specific enzymatic reaction. This metabolite is distinct from PGE2 in terms of its structure and function.

**Why it's important for research:**

1. **Distinct Biological Activity:** 19-OH-PGE2 has been shown to exert **different biological activities** compared to its parent molecule PGE2. For example, it has been shown to:
* **Promote anti-inflammatory responses:** In contrast to PGE2's pro-inflammatory effects, 19-OH-PGE2 can suppress inflammatory responses. This makes it a potential therapeutic target for inflammatory diseases.
* **Modulate immune responses:** It can impact the activity of immune cells like macrophages and T cells, potentially influencing the course of immune responses.
* **Influence cell growth and development:** 19-OH-PGE2 may have a role in regulating cell proliferation and differentiation, particularly in the nervous system and reproductive system.
2. **Marker of PGE2 Metabolism:** Measuring levels of 19-OH-PGE2 can provide insight into the **activity of specific enzymes involved in PGE2 metabolism**. This information is valuable for understanding how PGE2 signaling is regulated and potentially identifying new therapeutic targets.
3. **Potential Therapeutic Applications:** The unique activities of 19-OH-PGE2 have sparked interest in its potential as a **therapeutic agent** for various diseases. It is being investigated for its potential use in:
* **Treatment of inflammatory disorders:** Its anti-inflammatory properties make it a potential candidate for treating conditions like rheumatoid arthritis and inflammatory bowel disease.
* **Modulation of immune responses:** 19-OH-PGE2 could be explored for its potential to fine-tune immune responses in autoimmune disorders or cancer.
* **Neurological and reproductive applications:** Its effects on cell growth and development might lead to new therapies for neurological disorders and reproductive issues.

**Current Research:**

Currently, research on 19-OH-PGE2 is ongoing to:

* **Elucidate its precise mechanism of action:** Researchers are investigating how 19-OH-PGE2 exerts its effects at the molecular level.
* **Develop assays and tools for its detection and quantification:** Accurate measurement of 19-OH-PGE2 levels is crucial for understanding its role in various physiological and pathological processes.
* **Explore its potential as a therapeutic agent:** Preclinical studies are evaluating the efficacy and safety of 19-OH-PGE2 in treating various diseases.

**Overall, 19-OH-PGE2 represents a fascinating and promising area of research with significant potential to contribute to our understanding of prostaglandin signaling and potentially lead to new therapeutic approaches for a range of diseases.**

19-hydroxyprostaglandin E2: found in ram seminal fluid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6443793
MeSH IDM0140260

Synonyms (8)

Synonym
19-hydroxyprostaglandin e2
(z)-7-[(1r,2r,3r)-2-[(e,3s)-3,7-dihydroxyoct-1-enyl]-3-hydroxy-5-oxocyclopentyl]hept-5-enoic acid
55123-68-7
prosta-5,13-dien-1-oic acid, 11,15,19-trihydroxy-9-oxo-, (5z,11alpha,13e,15s)-
19(r)-hydroxy pge2
19(r)-oh pge2
DTXSID101316899
19-hydroxy pge2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]